Astellas sues Apotex for patent infringement

24-10-2016

Astellas sues Apotex for patent infringement

IgorUA / Shutterstock.com

Japanese drug company Astellas has filed a complaint against Canada-based Apotex for allegedly infringing its patents centring on the drug Myrbetriq (mirabegron).


Astellas, Apotex, ANDA, patent, Myrbetriq

LSIPR